About this trial
Cesarean section (CS) remains one of the most common major surgical procedures worldwide, with emergency CS accounting for approximately 30% of cases. Emergency CS presents unique challenges including increased maternal stress, higher complication rates, and prolonged recovery compared to elective procedures . Enhanced Recovery After Surgery (ERAS) protocols offer a promising approach to optimize outcomes in this population.
Originally developed for colorectal surgery, ERAS principles have been successfully adapted to obstetric practice over the past decade. These evidence-based protocols emphasize multimodal interventions including preoperative counseling, optimized analgesia, early mobilization, and timely nutrition. In obstetrics, ERAS implementation has demonstrated reduced length of stay, decreased opioid use, and improved patient satisfaction for elective CS .
Application of ERAS to emergency CS requires special considerations due to the urgent nature of the procedure. Modified protocols focus on rapid preoperative assessment, regional anesthesia with intrathecal opioids, and immediate postoperative care initiation . Emerging evidence suggests these adaptations maintain benefits while accommodating time constraints . Key outcomes include reduced postoperative pain, earlier return of bowel function, and improved breastfeeding rates .
Current research demonstrates ERAS protocols can be safely implemented in emergency CS with proper staff training and institutional support . Ongoing studies continue to refine optimal practices, particularly regarding fluid management and thromboprophylaxis . As evidence accumulates, standardized guidelines for emergency CS ERAS pathways are expected to emerge .
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
singleton pregnancy who undergoing emergency cesarean section after 34weeks and accepting to be included in the study.
Disqualifiers
Pregnant woman who had previous rupture uterus.
Other medical disorders as hypertensive disorder during pregnancy, cardiac disease.
Intra-operative complications necessitating changes in post-operative care e.g. bowel injury, urinary tract injury.
Hemodynamically unstable (post-partum hemorrhage)
Trial population
Pregnant patients admitted to Woman's Health hospital, Assiut university labor ward and post-partum.
Trial design
Other
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
assess the obstetric ObQOR11scrore at 12 hours and 24 hours post-operative
A data collection tool will be prepared for the study. After screening for eligibility, demographic factors, obstetric history. weight and gain, quality of previous cesarean scar if any, hemoglobin will be assessed for all patients. Observation of the outcomes will be recorded in the first phase of the study using a structured proforma and the Arabic version of ObQOR-11 score. Secondary outcomes measures include first oral intake, first abulation, first urination after catheter removal, passage of flatus and pain visual analog scale every 4 hours till discharge.
Secondary outcomes
Secondary outcome
Time to first oral intake
Secondary outcome
Time to passage of flatus
Secondary outcome
Time to first ambulation
Secondary outcome
Time to first urination after catheter removal
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: